Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Benlysta
Pharma
FDA rejects AZ's subcutaneous version of lupus drug Saphnelo
The FDA has rejected AstraZeneca's bid to gain an expansion for lupus drug Saphnelo to be administered subcutaneously in a prefilled pen.
Kevin Dunleavy
Feb 3, 2026 9:55am
AZ touts phase 3 lupus win for subcutaneous Saphnelo
Jan 6, 2026 11:44am
Samsung Bio shells out $280M to secure first US production site
Dec 22, 2025 9:14am
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
Oct 20, 2025 10:15am
Lupus landscape 'poised for evolution'
Sep 17, 2024 9:55am
GSK taps social media influencers to reach lupus community
Jul 21, 2023 4:00am
